Literature DB >> 15822393

[Gestational diabetes and urinary tract malformations: a hospital case-control study].

Arnaud Fotso Kamdem1, Antoine Burguet, Didier Aubert.   

Abstract

INTRODUCTION: Urinary tract malformations represent the leading cause of renal failure in children. Gestational diabetes plays a controversial role in the development of urinary tract malformations. The purpose of this study was to assess the role of insulin-requiring gestational diabetes on the development of ureteric malformations in children.
MATERIAL AND METHODS: The authors report the results of a prospective case-control survey (102 cases, 104 controls) conducted in a teaching hospital. The role of insulin-requiring gestational diabetes on the development of urinary tract malformations was tested by logistic regression after adjustment for risk factors for urinary tract malformations 'family history of urinary tract malformations, parity, smoking, substance abuse during pregnancy).
RESULTS: Gestational diabetes is a risk factor for urinary tract malfornations after adjustment (aOR=5.1; 95%CI: 1.1-24.5), and for ureteropelvic junction syndrome (aOR=6.5; 95%CI: 1.1-39.4) and vesicoureteric reflux (aOR=5.9; 95%CI: 1.1-32.1).
CONCLUSION: All perinatal healthcare professionals must be familiar with the concept of insulin-requiring gestational diabetes as an uncommon, but fairly powerful risk factor for ureteric malformations.

Entities:  

Mesh:

Year:  2005        PMID: 15822393

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  2 in total

Review 1.  Environmental factors for the development of fetal urinary malformations.

Authors:  Ming-Yan Hei; Zhu-Wen Yi
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

2.  Altered ureteric branching morphogenesis and nephron endowment in offspring of diabetic and insulin-treated pregnancy.

Authors:  Stacey N Hokke; James A Armitage; Victor G Puelles; Kieran M Short; Lynelle Jones; Ian M Smyth; John F Bertram; Luise A Cullen-McEwen
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.